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Background
The primary goal of any recombinant protein produc-
tion is to achieve successful gene transfer and expres-
sion in a target cell. There are two general categories of
delivery vehicles/vectors employed in protein expression
protocols. The first category includes the non-viral vec-
tors, ranging from direct injection of DNA to complex-
ing DNA with cationc lipds, polylysine, etc. The second
category comprises DNA and RNA viral vectors.
Viruses have evolved specific mechanism to deliver
their genetic material to target cell nuclei. Virus mem-
bers of family Retroviridae, e.g. retroviruses and lenti-
viruses, are among the most widely used viral vectors.
The use of lentiviral vectors has been increasing because
the vector system has attractive features. Lentiviruses
have an advantage over retroviruses in that they can
infect both dividing and non-dividing cells and therefore
have attracted much attention regarding the potential as
vectors for gene delivery/therapy. Once integrated into
the genome, recombinant cell lines are selected using
different selection mechanisms.
Results
Lentivirus particles were produced by simultaneous co-
transfection of HEK 293T cells with four plasmids. The
packaging construct (pMDLg/pRRE) [1], the VSV-G-
expressing construct (pMD.G) [2], the Rev-expressing
construct (pRSV-Rev) [1], and the self-inactivating (SIN)
lentiviral vector construct containing the green fluores-
cent protein (GFP) reporter gene (pLV-PLK-eGFP). The
medium containing lentiviral particles was collected 48
h after transfection, clarified by centrifugation 10 min at
2000 rpm and then stored at -80°C. To determine viral
titers, HEK 293T cells were seeded at 3 x 10
4 cell/ml in
6-well plates and mantained for 18 h. The supernatant
was replaced with 1 ml of diluted lentiviral particles
supernatant containing pLV-PLK-GFP, followed by incu-
bation overnight. Then, the supernatants were replaced
with fresh medium. The cells were analized by flow
cytometry and the percentage of GFP positive cells were
counted 96 h post transduction. Titer was calculated
from the dilutions at which the percentage of eGFP-
positive cells fall within the range of 1-30% using the
following formula [3,4]: Titer (TU/ml) = [F x C/V] x D;
where TU/ml: transduction units/ml, F: frequency of
GFP-positive cells, C: total number of cells in the well at
the time of transduction, V: volume of inoculum in ml,
and D: lentivirus dilution.
The viral titer was as high as 4.4 x 10
8 TU/ml.
After that, HEK 293T cells were seeded at a density of
6x1 0
4 cell/ml in 6-well plates and after 24 h the super-
natant was replaced by 1 ml medium containing lenti-
viral vectors. 96 h post-transduction the cells were
analyzed by flow cytometry (t=0); then, the cells were
incubated with the puromycin selection agent to obtain
stable recombinant cell lines. Two protocols were
employed: A-) Single-step selection protocol: the cells
were incubated with 1, 5, 10, 50, 100, 150, 200 and 250
µg/ml of puromycin in different plates, and B-) Multi-
step gradual selection protocol: the cells were incubated
from 1 up to 250 µg/ml of puromycin, but the selection
agent was gradually changed each 7 days on the same
plates (Table 1).
Once the cells were resistant to different concentra-
tions of puromycin, recombinant cell lines were
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pare the expression of eGFP (x-mean). Recombinant cell
lines showed different eGFP expression levels according
to puromycin concentration. The cell line CL200
showed the highest eGFP expression level (Figure 1).
Conclusions
Employing the gradual selection protocol, it was possible
to maintain the cells in culture condition up to 200 µg/
ml puromycin and achieve higher expression levels of
the reporter gene, between 2 and 6 times depending on
puromycin concentration. Contrarily, in the single-step
selection protocol cells cultures were resistant only up
to 50 µg/ml and expression levels of eGFP were lower.
Simultaneously, resistant cell lines were cloned by limit
dilution methods and the resulting cell clones were also
analyzed by flow cytometry. The eGFP expression of
each clone was consistent with the ones observed in the
respective resistant cell lines (data not shown). There-
fore, with this strategy of recombinant cell line selection,
it was possible to obtain high eGFP producing stable cell
clones without the use of any gene amplification system.
Published: 22 November 2011
References
1. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L: A
third-generation lentivirus vector with a conditional packaging system. J
Virol 1998, 72:8463-8471.
2. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM,
Trono D: In vivo gene delivery and stable transduction of nondividing
cells by a lentiviral vector. Science 1996, 272:263-267.
3. White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J, Halterman M,
Rimel BJ, Federoff H, Pandya S, et al: Lentivirus vectors using human and
simian immunodeficiency virus elements. J Virol 1999, 73:2832-2840.
4. Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta K: Titering lentiviral
vectors: comparison of DNA, RNA and marker expression methods. Gene
Ther 2002, 9:1155-1162.
doi:10.1186/1753-6561-5-S8-P7
Cite this article as: Prieto et al.: A strategy to obtain recombinant cell
lines with high expression levels. Lentiviral vector-mediated
transgenesis. BMC Proceedings 2011 5(Suppl 8):P7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Table 1 eGFP expression level of different recombinant cell lines according to puromycin concentration
Recombinant cell line Puromycyn (µg/ml) Single-step selection protocol Multistep gradual selection protocol
Fold increase eGFP expression (X-mean)
CL1 1 1.0 1.0
CL5 5 2.0 2.0
CL10 10 2.0 2.0
CL50 50 2.0 2.0
CL100 100 nv 4.5
CL150 150 nv 4.5
CL200 200 nv 6.0
CL250 250 nv nv
nv: non viable cells
Figure 1 Flow cytometry of different eGFP recombinant cell lines
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